Re-Engraftment of Prior Cord Blood Graft in a Patient with Relapsed/Refractory Acute Myeloid Leukaemia following Haploidentical Transplantation
Journal Title: International Journal of Stem Cell Research and Transplantation (IJST) - Year 2015, Vol 3, Issue 7
Abstract
We report the case of a 32-year-old man with poor risk acute myeloid leukemia (AML) who received transplantation of an UCB graft following myeloablative conditioning but unfortunately relapsed after one year with complete loss of donor chimerism. As this patient did not have an HLA - matched sibling donor or a volunteer MUD, he went on to receive a second transplant with haploidentical CD34 cells from his mother following a non-myeloablative conditioning. After initial engraftment with the haploidentical donor cells, the patient became progressively pancytopenic and chimerism analysis revealed decreased level of cells derived from the haploidentical graft. However, there was a concurrent increasing ratio of the UCB derived cells from the first transplant. The patient had eventual recovery and stabilization of his full blood count and repeat chimerism analysis demonstrated successful re-engraftment with the previous UCB graft. To the best of our knowledge, no such similar cases have been reported in the literature. Thus, cord blood cells from a prior transplant could remain present in small quantities at the phase ofleukemia relapse and re-emerge to establish long term hematopoiesis even after graft failure from a subsequent haploidentical transplant.
Authors and Affiliations
Lim Wei Inng Francesca Lorraine
Keywords
Related Articles
- EP ID EP197102
- DOI 10.19070/2328- 3548-1500021
- Views 90
- Downloads 0
Photo Documentation In Ocular Trauma
Objective: Aim of the study is to photograph different cases of ocular trauma to ensure the safety of an ophthalmologist in giving prognosis and avoiding problems which are faced in court of law in criminal cases. Study...
Mass Production of Stem Cell-Derived Progeny in Bioreactors
Mass Production of Stem Cell-Derived Progeny in Bioreactors
Vascular Regenerative Surgery: Promised Land for Tissue Engineers?
Cardiovascular cell therapy is a promising new field for the development of treatments for cardiovascular diseases, which remain a major cause of mortality around the world. In this review, we highlight the options curre...
Cancer Stem- Like Cells in Melanoma Progression, Resistance and Recurrence: Significance for Melanoma Treatment
Human malignant melanoma is a highly aggressive tumor which demonstrates heterogeneity and a propensity to drug resistance. Despite improved treatment options, patients with advanced malignant melanoma continue have a po...
Xenotransplantation for Renal Failure Patients: Evolution of Strategies
Xenotransplantation for Renal Failure Patients: Evolution of Strategies